In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

A warning has now been issued after ‘GLP-1 weight-loss patches’ were spotted online amidst the surge in Mounjaro popularity.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side ...

In 568 patients who underwent bariatric surgery, those who also used a GLP-1 receptor agonist during the preoperative and ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...